Quality control assessment of Human Immunodeficiency Virus type 2 (HIV-2) viral load quantification assays: Results from an international collaboration on HIV-2 infection in 2006

Journal of Clinical Microbiology

Volumn 46, Issue 6, 2008, Pages 2088-2091

  Damond, Florence ^a   Benard, Antoine ^b   Ruelle, Jean ^c   Alabi, Abraham ^d   Kupfer, Bernd ^e   Gomes, Perpetua ^f   Rodes, Berta ^g   Albert, Jan ^h,i   Böni, Jürg ^j   Garson, Jeremy ^k   Ferns, Bridget ^k   Matheron, Sophie ^a   Chene, Geneviève ^b   Brun Vezinet, Françoise ^a  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e UNIVERSITY OF BONN   (Germany)

^f HOSPITAL EGAS MONIZ   (Portugal)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j Swiss HIV Cohort Study   (Switzerland)

^k ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ASSAY; RNA ANALYSIS; VIRUS LOAD; VIRUS STRAIN;

COOPERATIVE BEHAVIOR; HIV INFECTIONS; HIV-2; HUMANS; INTERNATIONALITY; LABORATORIES; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 45149095391     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00126-08     Document Type: Article

References (13)

1. Anonymous. 1994. Accuracy (trueness and precision) of measurement methods and results - part 2: basic method for the determination of repeatability and reproducibility of a standard measurement method. International Organization for Standardization, Geneva, Switzerland.
2. Damond, F., G. Collin, D. Deseamps, S. Matheron, S. Pueyo, A. Taieb, P. Campa, A. Benard, G. Chene, and F. Brun-Vezinet. 2005. Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay. J. Clin. Microbiol. 43:4234-4236.
3. Ferns, R. B., and J. A. Garson. 2006. Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a brome mosaic virus internal control. J. Virol. Methods 135:102-108.
4. Kanki, P. J., K. U. Travers, S. MBoup, C. C. Hsieh, R. G. Marlink, N. A. Gueye, T. Siby, I. Thior, M. Hernandez-Avila, J. L. Sankale, et al. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943-946.
5. Matheron, S., S. Pueyo, F. Damond, F. Simon, A. Lepretre, P. Campa, R. Salamon, G. Chene, and F. Brun-Vezinet. 2003. Factors associated with clinical progression in HIV-2-infected patients: the French ANRS cohort. AIDS 17:2593-2601.
6. Muyldermans, G., L. Debaisieux, K. Fransen, D. Marissens, K. Miller, D. Vaira, A. M. Vandamme, A. T. Vandenbroucke, C. Verhofstede, R. Schuurman, G. Zissis, and S. Lauwers. 2000. Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories. Clin. Microbiol. Infect. 6:213-217.
7. Rodés, B., J. Sheldon, C. Toro, L. Cuevas, E. Perez-Pastrana, I. Herrera, and V. Soriano. 2007. Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1). J. Clin. Microbiol. 45:88-92.
8. Ruelle, J., B. K. Mukadi, M. Schutten, and P. Goubau. 2004. Quantitative real-time PCR on LightCycler for the detection of human immunodeficiency virus type 2 (HIV-2). J. Virol. Methods 117:67-74.
9. Schutten, M., B. van den Hoogen, M. E. van der Ende, R. A. Gruters, A. D. Osterhaus, and H. G. Niesters. 2000. Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma. J. Virol. Methods 88:81-87.
10. Smallman-Raynor, M., and A. Cliff. 1991. The spread of human immunodeficiency virus type 2 into Europe: a geographical analysis. Int. J. Epidemiol. 20:480-489.
11. Soriano, V., P. Gomes, W. Heneine, A. Holguin, M. Doruana, R. Antunes, K. Mansinho, W. M. Switzer, C. Araujo, V. Shanmugam, H. Lourenco, J. Gonzalez Lahoz, and F. Antunes. 2000. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 61:111-116.
12. Toro, C., V. Soriano, C. Tuset, A. Aguilera, E. Caballero, R. O. de Lejarazu, and B. Rodes. 2002. Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II. HIV Clin. Trials 3:397-402.
13. van der Ende, M. E., J. M. Prins, K. Brinkman, M. Keuter, J. Veenstra, S. A. Danner, H. G. Niesters, A. D. Osterhaus, and M. Schutten. 2003. Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients. AIDS 17(Suppl. 3):S55-S61.